MLYS Financials

Mineralys Therapeutics Inc - Financial statements & key metrics

Stock Price

$26.59

Market Cap

$2.10B

EPS

$-2.91

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-177.81M

EPS (Diluted)

$-3.66

Balance Sheet Highlights

Total Assets

$205.90M

Total Liabilities

Shareholders Equity

Cash & Equivalents

$114.09M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-166.31M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-0.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is MLYS revenue?

View MLYS's income statement for detailed revenue data.

Is MLYS profitable?

MLYS reported a loss of $177.81M in the most recent quarter.

What is MLYS market cap?

MLYS has a market capitalization of $2.10B, making it a mid-cap stock.

Does MLYS have debt?

View MLYS's balance sheet for debt information.

What is MLYS cash flow?

Cash flow data is available in the full financial statements.